Sinica Genomics

Medical Biology Division

2022

Hsiao, Michael

• Chan MH, Chang ZX, Huang CYF, Lee L, Liu RS, Hsiao M*, 2022, “Integrated Therapy Platform of Exosomal System: Hybrid Inorganic/organic Nanoparticles with Exosomes for Cancer Treatment [COVER STORY]”, NANOSCALE HORIZONS, E-pub, 1. (SCIE)
• Wen YC, Liu CL, Yeh HL, Chen WH, Jiang KC, Tram VT, Hsiao M, Huang J, Chen WY, Liu YN, 2022, “PCK1 Regulates Neuroendocrine Differentiation in A Positive Feedback Loop of LIF/ZBTB46 Signalling in Castration-resistant Prostate Cancer”, BRITISH JOURNAL OF CANCER, 126(5), 778-790. (SCIE)
• Wen YC, Chen WY, Yeh HL, Tram VTN, Chen WH, Jiang KC, Abou-Kheir W, Huang J, Hsiao M, Liu YN, 2022, “Pyruvate Kinase L/R Links Metabolism Dysfunction to Neuroendocrine Differentiation of Prostate Cancer by ZBTB10 Deficiency”, CELL DEATH & DISEASE, 13(3), 252. (SCIE)
• Chang YC, Li CH, Chan MH, Yeh CN, Chen MH, Hsiao M*, 2022, “Regorafenib Inhibits Epithelial-Mesenchymal Transition and Suppresses Cholangiocarcinoma Metastasis via the YAP1-AREG Axis”, CELL DEATH & DISEASE, 13, 391. (SCIE)
• Chan MH, Huang WT, Chen KC, Su TY, Chan YC, Hsiao M*, Liu RS, 2022, “The Optical Research Progress of Nanophosphors in Absorption and Diffuse Reflection of Near-Infrared Windows I and II for Deep-Tissue Theranostics”, NANOSCALE, In Press, 1. (SCIE)
• Chuang HH, Zhen YY, Tsai YC, Chuang CH, Hsiao M, Huang MS, Yang CJ, 2022, “FAK in Cancer: From Mechanisms to Therapeutic Strategies [INVITED REVIEW]”, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, Feb 2;23(3), 1726. (SCIE)
• Li LJ, Chang PM, Li CH, Lai TC, Chang YC, Su CY, Chen CL, Chang WM, Hsiao M*, Fung SW, 2022, “FAS receptor regulates NOTCH activity through ERK-JAG1 axis activation and controls oral cancer stemness ability and pulmonary metastasis”, CELL DEATH DISCOVERY, 8, 101. (SCIE)
• Chan MH, Huang WT, Satpathy A, Su TY, Hsiao M*, Liu RS, 2022, “Progress and Viewpoints of Multifunctional Composite Nanomaterials for Glioblastoma Theranostics”, PHARMACEUTICS, Feb 21;(14), 456. (SCIE)
• Chang YC, Chang PM, Li CH, Chan MH, Lee YJ, Chen MH, Hsiao M*, 2022, “Aldolase A and Phospholipase D1 Synergistically Resist Alkylating Agents and Radiation in Lung Cancer.”, FRONTIERS IN ONCOLOGY, Jan 21;11, 811635. (SCIE)
• Chou CC, Hua KT, Chen MW, Wu CJ, Hsu CH, Wang JT, Hsiao M, Wei LH, 2022, “Discovery and Characterization of A Monoclonal Antibody Targeting A Conformational Epitope of IL-6/IL-6Rα to Inhibit IL-6/ IL-6Rα/gp130 Hexameric Signaling Complex Formation”, MABS, 14(1), 2029675. (SCIE)
• Chang ZX, Li CH, Chang YC, Huang CYF, Chan MH, Hsiao M*, 2022, “Novel Monodisperse FePt Nanocomposites for T2-weighted Magnetic Resonance Imaging: Biomedical Theranostics Applications [COVER STORY]”, NANOSCALE ADVANCES, 4(2), 377-386. (SCIE) (IF: 　; 　)
• Tsai MT, Sun YS, Keerthi M, Panda AK, Dhawan U, Chang YH, Lai CF, Hsiao M, Wang HY, Chung RJ, 2022, “Oral Cancer Theranostic Application of FeAu Bimetallic Nanoparticles Conjugated with MMP-1 Antibody”, NANOMATERIALS, 12(1), 61. (SCIE)

Lin, Kuo-I

• Chang, L.-Y., Liang, S.-Y., Lu, S.-C., Tseng, H.-C., Tsai, H.-Y., Tang, C.-J., Sugata, M., Chen, Y.-J., Chen, Y. -J. Wu, S.-J., Lin, K.-I, Khoo, K.-H., and Angata, T., 2022, “Molecular basis and role of Siglec-7 ligand expression on chronic lymphocytic leukemia B cells”, Frontiers in Immunology, 13, 840388.
• Huang, H.-Y., Liao, H.-Y., Chen, X., Wang, S.-W., Cheng, C.-W., Shahed-Al-Mahmud, M. Chen, T.-H., Lo, J. M., Liu, Y.-M., Wu, Y.-M., Ma, H.-H., Chang, Y.-H., Tsai, H.-Y., Chou, Y.-C., Hsieh, Y.-P., Tsai, C.-Y., Huang, P.-Y., Chang, S.-Y., Chao, T.-L., Kao, H.-C., Tsai, Y.-M., Chen, Y.-H., Wu, C.-Y., Jan, J.-T., Cheng, T.-J. R., Lin, K.-I*, Ma, C*. and Wong, C.-H.*, 2022, “Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal models”, Science Translational Medicine, 14(639), eabm0899. (SCIE)
• Gebreyesus, S. T., Siyal, A. A., Kitata, R. B., Chen, S.-W., Enkhbayar, B., Angata, T., Lin, K.-I, Chen, Y.-J. and Tu., S.-L., 2022, “Streamlined single-cell proteomics by an integrated microfluidic chip and data-independent acquisition mass spectrometry”, NATURE COMMUNICATIONS, 13(1), 37. (SCIE)

Shen, Chia-Ning

• Hsu, F. C., H.L. Lee, Y.J. Chen, Y.A. Shen, M.H. Wu, W.S. Huang, Y.C. Tsai, S.D. Yeh, C.C. Kuo, L.S. Lu, C.N. Shen* and J.F. Chiou*, 2022, “A Few-Shot Learning Approach Assists in the Prognosis Prediction of Magnetic Resonance-Guided Focused Ultrasound for the Local Control of Bone Metastatic Lesions”, Cancers, 12, 445. (SCIE)
• Lo, S.M., S.H.Hwang, C.L. Liu, C.N. Shen, W.H. Hong, W.C. Yang, M.H. Lee, C.R.Shen, 2022, “Inhibiting TLR7 Expression in the Retinal Pigment Epithelium Suppresses Experimental Autoimmune Uveitis”, Frontiers in Immunology, 12, 736251. (SCIE)

Yang, Hwai-I

• Tai AS, Huang YT, Yang HI, Lan LV, Lin SH, 2022, “G-Computation to Causal Mediation Analysis With Sequential Multiple Mediators-Investigating the Vulnerable Time Window of HBV Activity for the Mechanism of HCV Induced Hepatocellular Carcinoma.”, Frontiers in public health, 9, 757942. (SSCI) (IF: 2.483; SSCI ranking: 25.1%)
• Wu HC*, Jeng WJ, Pan MH, Hsieh YC, Lu SN, Chen CJ, Yang HI*, 2022, “Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection.”, JHEP reports : innovation in hepatology, 4(2), 100410-doi: 10.1016/j.jhepr.2021.100410.
• Wen-Juei Jeng, Mei-Hung Pan, Hwai-I Yang*, 2022, “Letter: sPD‐1 as a predictor for HBsAg seroconversion—shed light on inactive carriers with chronic hepatsitis B. Authors' reply”, ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 55(8), 1057-1058. (SCIE)
• Park J, Le AK, Tseng TC, Yeh ML, Jun DW, Trinh H, Wong GLH, Chen CH, Peng CY, Kim SE, Oh H, Kwak MS, Cheung KS, Toyoda H, Hsu YC, Jeong JY, Yoon EL, Ungtrakul T, Zhang J, Xie Q, Ahn SB, Enomoto M, Shim JJ, Cunningham C, Jeong SW, Cho YK, Ogawa E, Huang R, Lee DH, Takahashi H, Tsai PC, Huang CF, Dai CY, Tseng CH, Yasuda S, Kozuka R, Li J, Wong C, Wong CC, Zhao C, Hoang J, Eguchi Y, Wu C, Tanaka Y, Gane E, Tanwandee T, Cheung R, Yuen MF, Lee HS, Yu ML, Kao JH, Yang HI, Nguyen MH, 2022, “Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine.”, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 20(4), 874-885. (SCIE)
• Hu HH, Jeng WJ, Pan MH, Luo WS, Chang CL, Huang YT, Su CY, Chiang CT, Jen CL, Chien YC, Lu SN, Wang LY, Huang LR, Lee MH, Liu J, Nguyen MH, Chen CJ, Yang HI*, 2022, “Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis B.”, ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 55(5), 558-567. (SCIE)
• Chu YJ, Jeng WJ, Pan MH, Hu HH, Luo WS, Su CY, Chiang CT, Jen CL, Chen CJ, Yang HI*, 2022, “Serum soluble programmed death-1 levels predict the spontaneous HBeAg seroclearance in chronic hepatitis B.”, Journal of gastroenterology, doi: 10.1007/s00535-022-01874-8, Online ahead of print. (SCIE)
• Jeng Wen-Juei*, Chen Chien-Hung*, Wang Yi-Wen, Pan Mei-Hung, Lin Chia-Wei, Lin Chun-Yen, Yang Hwai-I*, 2022, “The association between sPD-1 levels versus liver biochemistry and viral markers in chronic hepatitis B patients: a comparative study of different sPD-1 assays”, Virology Journal, 19(1), 59-10.1186/s12985-022-0. (SCIE)